Related Experiment Video
Updated: Jul 29, 2026
08:53
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Current advances in Hodgkin's lymphoma.
Joseph Vadakara1, Benjamin Andrick1
1Department of Hematology and Oncology, Geisinger Medical Center, Danville, PA 17822, USA.
Chronic Diseases and Translational Medicine
|April 18, 2019
Summary
Hodgkin
Area of Science:
- Hematology
- Oncology
- Immunotherapy
Background:
- Hodgkin's lymphoma is a curable cancer, but some patients do not respond to initial treatment.
- Conventional chemotherapy has been the standard, but new therapies offer improved outcomes.
- Relapsed or refractory disease presents significant challenges in patient management.
Purpose of the Study:
- To review recent advancements in treating Hodgkin's lymphoma.
- To discuss the impact of novel therapies like brentuximab vedotin and immune checkpoint inhibitors.
- To highlight ongoing clinical trials shaping future treatment strategies.
Main Methods:
- Literature review of current Hodgkin's lymphoma management.
- Analysis of recent clinical trial data and therapeutic outcomes.
- Synthesis of information on novel therapeutic agents and their mechanisms.
Main Results:
- Brentuximab vedotin and immune checkpoint inhibitors have transformed Hodgkin's lymphoma treatment.
- These newer therapies show promise in patients with relapsed or refractory disease.
- Ongoing trials are exploring combination therapies and personalized treatment approaches.
Conclusions:
- Modern therapeutic strategies have significantly improved Hodgkin's lymphoma care.
- Further research through clinical trials is crucial for optimizing treatment and achieving higher cure rates.
- The field is rapidly evolving, offering new hope for patients with difficult-to-treat disease.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...